The International Society for
Heart and Lung Transplantation

A Society that Includes Basic Science, the Failing Heart and Advanced Lung Disease.

In the Spotlight

Well, That's a Wrap!

It's hard to believe that both the conference -- and my year as ISHLT president -- are in the books. Both were incredible experiences that underscore why the Society is so important to me, professionally and personally. 
Serving as President has been a tremendous honor -- and for so many reasons. I've worked with such committed people, from my fellow volunteers to our staff. I've met new people from around the world and across disciplines. And I've had the opportunity to really dig into the organization and think about our role within the medical community. Read more

Today's Highlights

A Round of Applause for Our Award Winners

In a year full of stellar submissions, it was no easy feat for the Awards Committees to select the winners. Congratulations to everyone who submitted work. The ISHLT2019 Award Winners are listed here! Read more

Ring Around the Azoles:  What’s the Interaction with Isavuconazonium?

Isavuconazonium Pharmacokinetic Interactions with Immunosuppression in Thoracic Transplant Recipients
Carrie Burt, PharmD, MPH
Azole antifungals (e.g. voriconazole, posaconazole, itraconazole) are commonly used to prevent and treat fungal infections in the cardiothoracic transplant population.  However, their use is complicated by their inhibition of cytochrome P450 (CYP) enzymes, particularly CYP3A4.  This inhibition is clinically significant as it will interact with many of our workhorse immunosuppressive agents, particularly our calcineurin and mTOR inhibitors.  This interaction can be profound and well documented and empiric adjustments to immunosuppressive doses are commonly recommended.   Read more

Warning: You’re Losing Lung Transplants by Not Using Scleroderma Patients

Scleroderma: The Ability to Swallow is Optional
Maria Crespo, MD
Scleroderma is a connective tissue disease that involves the hardening and tightening of the skin and connective tissues and can involve the digestive tract, heart, lungs, and kidneys.  Patients with scleroderma are considered suboptimal lung transplant candidates due to: Small chest cavities and severe pulmonary hypertension, Esophageal dysmotility and gastroesophageal reflux disease (GERD), Increased risk for renal insufficiency, Extra-pulmonary manifestations. Read more

Final Plenary Session at ISHLT2019

The final Plenary session of ISHLT2019 included the President’s Debate – a rousing look at Retransplantation – as well as two What’s Hot. What’s New sessions. Read on for the highlights:  Read more

#ISHLT2019 Announcements

Welcome to the New ISHLT Board of Directors

We’re pleased to present the recently-elected Directors and Officers for the ISHLT Board of Directors -- term April 2019-April 2022! Read more

We Want Your Opinions! Be Sure to Take the Survey

Help us make next year’s event as strong as possible by giving us feedback. Take the survey. You’ll find it in the app under Attendee Information or click here to take it online. 
Thanks in advance from the ISHLT Staff!

Claiming CME for ISHLT2019 is Easy

Need to Continuing Medical Education for ISHLT2019 or the ISHLT Academies? Here’s how to get your certificate.

  1. Go online here.
  2. Visit the ISHLT 39thAnnual Meeting and Scientific Sessions link. 
  3. Choose which profession you need credit for and click on that link.

Questions? Email

On the Horizon

See You Next Year – And the One After That!

April 22-25, 2020
Palais de Congrès de Montréal
Montréal, Canada
April 21-24, 2021
International Convention Center Sydney
Sydney, Australia
Mark your calendars now!

Disclaimer: This content reflects the opinions and perspectives of the individual authors and does not reflect the opinions and perspectives of the ISHLT or the Editor.